Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

5.920 USD UNCHANGED
Streaming Delayed Price Updated: 8:00 AM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cerus Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Cerus Appoints Eric Bjerkholt to Board of Directors
Cerus Corporation (Nasdaq: CERS) today announced the appointment of Eric Bjerkholt to its Board of Directors. Mr. Bjerkholt currently serves as the chief financial officer of Aimmune Therapeutics, a... 
From Business Wire News Releases
Cerus to Host Institutional Investor Meeting
Cerus Corporation (Nasdaq: CERS) today announced that it will host an Institutional Investor Meeting on Tuesday, October 16, 2018 in Boston, Massachusetts. 
From Business Wire News Releases
Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
Cerus Corporation (Nasdaq: CERS) today announced that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, will present and provide a corporate update at the Cantor Fitzgerald 2018... 
From Business Wire News Releases
Cerus Appoints Timothy L. Moore to Board of Directors
Cerus Corporation (Nasdaq:CERS) today announced the appointment of Timothy L. Moore to its Board of Directors. Mr. Moore, who currently serves as executive vice president, technical operations for... 
From Business Wire News Releases
Cerus to Present at the Baird 2018 Global Healthcare Conference
Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ vice president, finance and chief financial officer, will present and provide a corporate update at the Baird 2018 Global... 
From Business Wire News Releases
New Research Coverage Highlights Evertec, Cerus, REV Group, U.S. Silica, The Manitowoc, and World Fuel Services — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Evertec, Inc. (NYSE:EVTC),... 
From GlobeNewswire News Releases
Cerus Corporation Reports Second Quarter 2018 Results
Cerus Corporation (Nasdaq: CERS) announced today financial results for the second quarter ended June 30, 2018, and raised its full year guidance for product revenue. 
From Business Wire News Releases
Cerus to Release Second Quarter 2018 Results on August 2, 2018
Cerus Corporation (Nasdaq:CERS) announced today that its second quarter results will be released on Thursday, August 2, 2018, after the close of the stock market. The company will host a conference... 
From Business Wire News Releases
New Navy Policy Implements Full Adoption of Pathogen-Reduced Apheresis Platelets Collected at U.S. Navy Blood Donor Centers
Cerus Corporation (Nasdaq: CERS) announced today that the U.S. Department of the Navy will implement pathogen-reduction for all apheresis platelets collected at Navy Blood Donor Centers. 
From Business Wire News Releases
Report: Developing Opportunities within Torchmark, Cerus, American Equity Investment Life Holding, Southern Copper, F5 Networks, and Diebold Nixdorf — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Torchmark Corporation... 
From GlobeNewswire News Releases
Cerus Corporation Sees Product Demand Double, Revises Guidance Upward
From ACCESSWIRE
Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association
Cerus Corporation (Nasdaq: CERS) announced that results from SPARC, the Company’s European Phase 3 study evaluating the efficacy and safety of INTERCEPT-treated red blood cells (RBCs) in thalassemia... 
From Business Wire News Releases
Cerus Announces Presentations Highlighting INTERCEPT Blood Systems at the 35th International Congress of the International Society of Blood Transfusion
Cerus Corporation (Nasdaq: CERS) today announced that it will make multiple presentations, including two oral abstracts, that will be featured at the 35th International Congress of the International... 
From Business Wire News Releases
Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells
Cerus Corporation (Nasdaq: CERS) today announced an amendment to the Company’s contract with the Biomedical Advanced Research and Development Authority (BARDA). The expansion of the agreement provides... 
From Business Wire News Releases
New Research Coverage Highlights Cerus, Health Insurance Innovations, Tetra Tech, Ferro, Dril-Quip, and MSC Industrial Direct — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cerus Corporation... 
From GlobeNewswire News Releases
Cerus Corporation Reports First Quarter 2018 Results
Cerus Corporation (Nasdaq:CERS) announced today financial results for the first quarter ended March 31, 2018, and raised its full year guidance for product revenue. 
From Business Wire News Releases
Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018
Cerus Corporation (Nasdaq: CERS) announced today that Dr. Laurence M. Corash, co-founder and chief scientific officer, and Lainie Corten, vice president of global marketing, are scheduled to present a... 
From Business Wire News Releases
Cerus to Release First Quarter 2018 Results on May 8, 2018
Cerus Corporation (Nasdaq:CERS) announced today that its first quarter results will be released on Tuesday, May 8, 2018, after the close of the stock market. The company will host a conference call and... 
From Business Wire News Releases
Cerus Announces Health Canada Approval of the INTERCEPT Blood System for Platelets
Cerus Corporation (Nasdaq: CERS) announced today that Health Canada has approved the commercialization of INTERCEPT Blood System for platelets. The INTERCEPT Blood System for platelets is intended for... 
From Business Wire News Releases
Cerus’ RedeS Phase 3 Red Blood Cell Study Expands Into the Continental U.S.
Cerus Corporation (NASDAQ: CERS) announced today that Baylor St. Luke’s Medical Center in Houston became the first center in the continental U.S. to enroll patients in Cerus’ RedeS study. RedeS is a... 
From Business Wire News Releases
Cerus Corporation, Shares Up 39% in the Past Month, Analysts Review, INTERCEPT
From ACCESSWIRE
Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer
Cerus Corporation (NASDAQ: CERS) announced today that The Community Blood Center (CBC) of Appleton, Wisconsin received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License... 
From Business Wire News Releases
Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and year ended December 31, 2017. 
From Business Wire News Releases
Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018
Cerus Corporation (NASDAQ: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company 38th... 
From Business Wire News Releases
Cerus to Release Fourth Quarter and Year End 2017 Results on March 8, 2018
Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2017 will be released on Thursday, March 8, 2018, after the close of the stock market. The company will... 
From Business Wire News Releases
Detailed Research: Economic Perspectives on REV Group, CoreLogic, Nu Skin Enterprises, Torchmark, Evertec, and Cerus — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REV Group, Inc.... 
From GlobeNewswire News Releases
Cerus Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Cerus Corporation (NASDAQ:CERS) today announced the closing of a registered underwritten public offering of its common stock, which included the sale of additional shares of common stock upon full... 
From Business Wire News Releases
Cerus Announces Pricing of Public Offering of Common Stock
Cerus Corporation (NASDAQ:CERS) today announced the pricing of a registered underwritten public offering of its common stock for proceeds of $50.0 million, before deducting estimated offering expenses... 
From Business Wire News Releases
Cerus Announces Public Offering of Common Stock
Cerus Corporation (NASDAQ: CERS) today announced that it has commenced a registered underwritten public offering of $50.0 million of its common stock. In addition, Cerus has granted the underwriter a... 
From Business Wire News Releases
Cerus Reports Positive Top-Line Results from Chronic Anemia Phase 3 Study Evaluating INTERCEPT Red Blood Cells in Thalassemia Patients
Cerus Corporation (NASDAQ: CERS) today reported that the primary efficacy and safety endpoints were successfully achieved in the company’s Phase 3 transfusion study of chronic anemia evaluating... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.